↓ Skip to main content

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

Overview of attention for article published in Trials, August 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 tweeters

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION
Published in
Trials, August 2022
DOI 10.1186/s13063-022-06609-x
Pubmed ID
Authors

Jan Kloka, Benjamin Friedrichson, Stephanie Dauth, Ann Christina Foldenauer, Anita Bulczak-Schadendorf, Maria J. G. T. Vehreschild, Francisco Maio Matos, Antoni Riera-Mestre, Antoinette D. I. van Asselt, Edoardo De Robertis, Vilma Traskaite Juskeviciene, Patrick Meybohm, Dana Tomescu, Karine Lacombe, Coen D. A. Stehouwer, Kai Zacharowski, Oliver Old, Markus Ketomaeki, Lea Grebe, Patrick Booms, Simone Lindau, Sebastian Zinn, Isabel Maushagen, Timo Wolf, Christoph Stephan, Cathy Weynants, Sylvia Daamen, Petra Wülfroth, Thomas Steiner, Marinus van Hulst, Peter Kranke, Sebastian Hottenrott, Tobias Schlesinger, Benedikt Schmid, Daniel Röder, Eva Kranke, Tobias Haas, Philipp Schlesinger, Magdalena Sitter, Davide Valeri, Raquel Torres Iglesias, José María Mora-Luján, Adriana Iriarte, Pau Cerdà, Neringa Vaguliene, Andrius Macas, Jolanta Litviniene, Kristina Balne, Catarina Monteiro, Inês Antunes Ferreira, Patrícia Couceiro, Pedro Soares, Sofia Beirão, Yasmine Abi Aad, Thibault Chiarabini, Mihai Popescu, C. J. H. van der Kallen, Kloka, Jan, Friedrichson, Benjamin, Dauth, Stephanie, Foldenauer, Ann Christina, Bulczak-schadendorf, Anita, Vehreschild, Maria J. G. T., Matos, Francisco Maio, Riera-mestre, Antoni, Van Asselt, Antoinette D. I., De Robertis, Edoardo, Juskeviciene, Vilma Traskaite, Meybohm, Patrick, Tomescu, Dana, Lacombe, Karine, Stehouwer, Coen D. A., Zacharowski, Kai, Old, Oliver, Ketomaeki, Markus, Grebe, Lea, Booms, Patrick, Lindau, Simone, Zinn, Sebastian, Maushagen, Isabel, Wolf, Timo, Stephan, Christoph, Weynants, Cathy, Daamen, Sylvia, Wülfroth, Petra, Steiner, Thomas, Van Hulst, Marinus, Kranke, Peter, Hottenrott, Sebastian, Schlesinger, Tobias, Schmid, Benedikt, Röder, Daniel, Kranke, Eva, Haas, Tobias, Schlesinger, Philipp, Sitter, Magdalena, Valeri, Davide, Iglesias, Raquel Torres, Mora-luján, José María, Iriarte, Adriana, Cerdà, Pau, Vaguliene, Neringa, Macas, Andrius, Litviniene, Jolanta, Balne, Kristina, Monteiro, Catarina, Ferreira, Inês Antunes, Couceiro, Patrícia, Soares, Pedro, Beirão, Sofia, Aad, Yasmine Abi, Chiarabini, Thibault, Popescu, Mihai, Van Der Kallen, C. J. H., On Behalf Of The Ixion Collaboration Group

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 36%
Professor 1 9%
Student > Bachelor 1 9%
Student > Master 1 9%
Unknown 4 36%
Readers by discipline Count As %
Unspecified 4 36%
Medicine and Dentistry 2 18%
Unknown 5 45%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2022.
All research outputs
#7,416,242
of 22,675,759 outputs
Outputs from Trials
#2,696
of 5,819 outputs
Outputs of similar age
#140,829
of 431,189 outputs
Outputs of similar age from Trials
#68
of 203 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,819 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,189 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 203 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.